The Long-Term Outcome of Boys With Partial Androgen Insensitivity Syndrome and a Mutation in the Androgen Receptor Gene
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In boys with suspected partial androgen insensitivity syndrome (PAIS), systematic evidence that supports the long-term prognostic value of identifying a mutation in the androgen receptor gene (AR) is lacking. OBJECTIVE: To assess the clinical characteristics and long-term outcomes in young men with suspected PAIS in relation to the results of AR analysis. METHODS: Through the International Disorders of Sex Development Registry, clinical information was gathered on young men suspected of having PAIS (n = 52) who presented before the age of 16 years and had genetic analysis of AR. RESULTS: The median ages at presentation and at the time of the study were 1 month (range, 1 day to 16 years) and 22 years (range, 16 to 52 years), respectively. Of the cohort, 29 men (56%) had 20 different AR mutations reported. At diagnosis, the median external masculinization scores were 7 and 6 in cases with and without AR mutation, respectively (P = .9), and median current external masculinization scores were 9 and 10, respectively (P = .28). Thirty-five men (67%) required at least one surgical procedure, and those with a mutation were more likely to require multiple surgeries for hypospadias (P = .004). All cases with an AR mutation had gynecomastia, compared to 9% of those without an AR mutation. Of the six men who had a mastectomy, five (83%) had an AR mutation. CONCLUSIONS: Boys with genetically confirmed PAIS are likely to have a poorer clinical outcome than those with XY DSD, with normal T synthesis, and without an identifiable AR mutation. Routine genetic analysis of AR to confirm PAIS informs long-term prognosis and management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions
Heinlein, C. A., & Chang, C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0070 · Cited by 568 · cited 2×
“28 Hypospadias at first presentation (Prox, Mid, Dis, NK) 20 (69) (15, 2, 1, 2) 20 (87) (13, 0, 6, 1) .”
BackgroundAndrogen receptor–mediated inhibition of cutaneous wound healing
Ashcroft, G. S., & Mills, S. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215704 · Cited by 255 · cited 1×
“Thus, the poor results are more likely to be related to defective androgen signaling and its links to tissue healing (19).”
BackgroundThe differential role of androgens in early human sex development
Hiort, O. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-152 · Cited by 87 · cited 6×
“Defects in androgen synthesis or action in a 46, XY infant can give rise to a very variable phenotype, ranging from normal female external genitalia to various grades of undermasculinization of male genitalia (2).”
BackgroundInfluentialSelf-citationHolmboe, S. A., Vradi, E., Jensen, T. K., Linneberg, A., Husemoen, L. L. N., Scheike, T., Skakkebæk, N. E., Juul, A., & Andersson, A.-M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2460 · Cited by 63 · cited 1×
“Even mildly impaired Leydig cell function in otherwise healthy subjects with low-normal T and elevated LH levels is associated with increased mortality and morbidity (39).”
BackgroundSelf-citation
Cited by
Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance
Handelsman, D. J., Hirschberg, A. L., & Bermon, S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00020 · Cited by 594
Caring for individuals with a difference of sex development (DSD): a Consensus Statement
Cools, M., Nordenström, A., Robeva, R., Hall, J., Westerveld, P., Flück, C., Köhler, B., Berra, M., Springer, A., Schweizer, K., et al. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0010-8 · Cited by 461
Self-citationHUNTER, S. K., S. ANGADI, S., BHARGAVA, A., HARPER, J., HIRSCHBERG, A. L., D. LEVINE, B., L. MOREAU, K., J. NOKOFF, N., STACHENFELD, N. S., & BERMON, S. (2023) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003300 · Cited by 241
Nordenström, A., Ahmed, S. F., van den Akker, E., Blair, J., Bonomi, M., Brachet, C., Broersen, L. H. A., Claahsen-van der Grinten, H. L., Dessens, A. B., Gawlik, A., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0073 · Cited by 108
Self-citationKyriakou, A., Dessens, A., Bryce, J., Iotova, V., Juul, A., Krawczynski, M., Nordenskjöld, A., Rozas, M., Sanders, C., Hiort, O., et al. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0534-8 · Cited by 78
“Such databases exist in many regional and national centres, as 90 % of the centres in this study reported keeping a DSD database, and to date have provided invaluable insight into several aspects of DSD including epidemiology [14, 15], aetiology [16], disease expression [17] and long-term outcome [18, 19].”
BackgroundSelf-citationHunter, S. K., Angadi, S. S., Bhargava, A., Harper, J., Hirschberg, A. L., Levine, B. D., Moreau, K. L., Nokoff, N. J., Stachenfeld, N. S., & Bermon, S. (2023) · Translational Journal of the American College of Sports Medicine · doi:10.1249/tjx.0000000000000236 · Cited by 43
Metadata
- Authors
- Lucas-Herald, A., Bertelloni, S., Juul, A., Bryce, J., Jiang, J., Rodie, M., Sinnott, R., Boroujerdi, M., Lindhardt Johansen, M., Hiort, O., Holterhus, P. M., Cools, M., Guaragna-Filho, G., Guerra-Junior, G., Weintrob, N., Hannema, S., Drop, S., Guran, T., Darendeliler, F., Nordenstrom, A., Hughes, I. A., Acerini, C., Tadokoro-Cuccaro, R., & Ahmed, S. F.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-11
- Volume
- 101
- Issue
- 11
- Pages
- 3959-3967
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2469917194
- Cited by
- 111
- References
- 4
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.